Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007963
Filing Date
2016-08-12
Accepted
2016-08-12 16:07:09
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cori-20160630x10q.htm 10-Q 1718910
2 EX-10.1 cori-20160630ex10168166c.htm EX-10.1 17034
3 EX-31.1 cori-20160630ex31130e5e2.htm EX-31.1 13182
4 EX-31.2 cori-20160630ex312b4da41.htm EX-31.2 13115
5 EX-32.1 cori-20160630ex321afbe15.htm EX-32.1 9186
6 EX-32.2 cori-20160630ex32259ba34.htm EX-32.2 8889
  Complete submission text file 0001558370-16-007963.txt   5780623

Data Files

Seq Description Document Type Size
7 EX-101.INS cori-20160630.xml EX-101.INS 1109037
8 EX-101.SCH cori-20160630.xsd EX-101.SCH 42376
9 EX-101.CAL cori-20160630_cal.xml EX-101.CAL 43446
10 EX-101.DEF cori-20160630_def.xml EX-101.DEF 143339
11 EX-101.LAB cori-20160630_lab.xml EX-101.LAB 409570
12 EX-101.PRE cori-20160630_pre.xml EX-101.PRE 282209
Mailing Address 235 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 235 CONSTITUTION DRIVE MENLO PARK CA 94025 650-298-8012
Corium International, Inc. (Filer) CIK: 0001594337 (see all company filings)

EIN.: 383230774 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-36375 | Film No.: 161828270
SIC: 2834 Pharmaceutical Preparations